StockWatch
·

Dixon Technologies (India) Ltd Q1 FY27 Results

DIXONQ1 FY27 Results
Filing
Result:Steady· Market: DownOne-off gainMargin squeezeBase effect

Beat/Miss: Miss · Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValueQ4 FY26Q1 FY26
Revenue15.5K Cr47.9%21.1%
Total Income16.1K Cr51.7%25.2%
Expenditure15.2K Cr48.7%21.9%
PBT860.34 Cr136.3%139.8%
Net Profit717.83 Cr140.9%156.3%
OPM2.98%0.91pp0.78pp
NPM4.47%1.66pp2.29pp
EPS118.00139.7%153.9%
View full financials

Consumer/manufacturing lens on adjusted PAT shows only ~7% YoY growth with underlying PBT margin compressing to ~2.3% from 2.85% as the mobile PLI tailwind fades, while reported revenue missed street estimates.

DIXON · Q1 FY27 · THE VERDICT

Market Share Gains Mask a 3% Margin Squeeze; Recovery Delayed to FY28

Dixon Technologies' Q1 delivered 21% revenue growth and smartphone market share gains, but operating profit was squeezed to just 3% by PLI1's expiry and input cost inflation. Reported PAT of ₹718 crores hinges on a ₹499-crore fair-value gain; strip that out and organic profit is only ₹219 crores, up just 20% YoY. Management explicitly defers margin recovery to FY28, pushing profitability upside to unproven component catalysts.

16 Aug 2026 · 6 min read
Reported PAT

₹718 Cr

+157% YoY, includes ₹499 Cr FV gain

Operating PAT (adjusted)

₹219 Cr

+~20% YoY, organic growth only

Operating margin

3.0%

down from 5%+ prior; no FY27 recovery expected

Dixon Technologies' Q1 result is a study in diverging narratives. On the surface, ₹15,547 crores in revenue (+21% YoY) and 7.5M smartphone units shows the company is winning market share in a market declining 10–12% industry-wide. But look at the bottom line: reported PAT of ₹718 crores is inflated by a ₹499-crore fair-value gain from Aditya Infotech. Strip that out, and operating profit is just ₹219 crores—a +20% organic growth that fails to keep pace with revenue expansion, revealing a margin compression story that management explicitly says will not improve this fiscal year.

The profit breakdown: Where ₹718 crores really came from

Of the ₹718 crores reported PAT, ₹499 crores is a mark-to-market gain on Aditya Infotech (the Q Tech camera module acquisition). That leaves ₹219 crores of operating profit—a 1.4% PAT margin when revenue touches ₹15,547 crores. The 3.0% operating margin (EBIT level) reflects the acute squeeze from Mobile PLI1's expiry and elevated input costs (memory prices, FX impacts, commodity inflation). This is not a one-quarter blip: management was explicit on the call that no margin recovery is expected in FY27, pushing profitability uplift to FY28 and beyond, when display and camera modules scale production.

Not expecting margin improvement from here onwards, of course, in [the current year].
Q1 FY27 Profit, ₹ Cr
0268.05536.11804.16718Reported499FV gain (one-time)219Adjusted (organic)
68% of reported PAT is a one-time fair-value gain. Organic operating profit of ₹219 crores reveals the true margin picture: 1.4% of revenue, up ~20% YoY but substantially slower than revenue growth of 21%.
What management said on the call — what the numbers actually show

Strong revenue growth despite smartphone market down 10–12% industry-wide

Supported

Revenue ₹15,547 Cr (+21% YoY); 7.5M mobile units with market share gains confirmed in declining market.

Mobile PLI1 sunset and elevated input costs compressed margins

Supported

Operating margin 3.0% (down from 5%+ historical). Management attributed to cost-plus pass-through and commodity inflation.

Expected 20–25% QoQ growth Q1 to Q2 in smartphone volumes

Supported

Q2 order book 9–9.2M units confirmed by CFO; Q1 was 7.5M, implying 20–23% QoQ growth.

No margin recovery FY27; recovery from FY28 when components scale

Supported

Management explicit: no margin improvement expected within current fiscal. Display factory trial Q3, mass production Q4; ramp takes quarters. Realistic timeline.

Flat year-over-year 32M units for full FY27 (market share gain in declining market)

Partial

H1 guided 16–16.5M units; implies H2 also ~16M to achieve ~32M full year. Feasible but H2 visibility lower than H1.

What changed on this call

Three material shifts from prior calls: First, management provided explicit FY27 guidance for Telecom segment at ₹6,700–7,000 crores (vs prior vague 'strong growth' language), implying 35–40% growth from ₹5,000 crores base. That's ambitious but credible, driven by 5G infrastructure, FWA broadband adoption, and Gemtek optical transceiver JV ramping Q3+. Second, IT Hardware momentum is ahead of expectations—Q1 alone ₹1,350 crores annualizes to ~₹5,400 crores, nearly the entire FY26 contribution, driven by Inventec JV and SSD manufacturing. Third, and most important: margin recovery timeline has slipped 12 months. Prior calls implied sequential margin improvement; now management is explicit that FY27 will see no OPM recovery, deferring uplift to FY28+ when component production (display, camera) reaches meaningful volumes. This is a downgrade to near-term profitability expectations.

The bull-bear ledger
  • Market share gains in a -10–12% market (7.5M units, volume momentum)

  • FY27 revenue growth tracking or beating 15–17% guidance (Q1 at +21%)

  • Explicit catalyst calendar: Vivo Q3, display Q3–Q4, IT hardware Q4, telecom ₹6,700–7,000 Cr

  • Operating margin at 3.0% (down 40–50% from global EMS baseline)

  • Margin recovery deferred 12 months; no FY27 improvement despite growth

  • Q Tech integration underperforming prior margin targets (FX blamed, but capacity ramp also lagging)

  • Smartphone market structurally declining; flat FY27 volume guidance depends on share gains proving sustainable

  • Reported PAT inflated by ₹499 Cr one-time FV gain (68% of bottom line)

Risks, ranked by severity and holder concern

Input cost inflation (memory, FX) persists; margin pass-through limited

High

Memory prices up or flat for duration; INR–CNY FX remains unfavorable. Pass-through to OEMs constrained by cost-plus contracts. 3% OPM may compress further if commodity inflation unabates.

Smartphone market contracting globally; Dixon's 32M unit guidance depends on sustained share gains

High

Industry down 10–12% globally. Dixon's flat guidance is a share-gain bet. If market declines faster or share capture plateaus, volume growth at risk, threatening FY27 revenue target.

JV and capacity execution risk (Vivo Q3, display Q3–Q4, Inventec Q4, camera scaling)

High

Four major catalysts in rapid succession. Any timeline slip (customer wins delayed, yield issues, supply chain disruptions) pushes margin recovery past FY28, extending the profitability trough.

Q Tech acquisition underperforming margin targets; FX blamed but integration lagging

Medium

Pre-acquisition 6–8% EBITDA margin; now subdued. Camera volume expansion (70M to 190M) should fix it, but prior margin misses raise confidence on the uplift trajectory.

PLI 2 scheme guidelines not finalized; export incentive structure and retention uncertain

Medium

Current exports ₹1,100 Cr; 2-year PLI 2 upside ₹18,000–20,000 Cr claimed. But structure (2.5–5% export band, 1.5% localization) subject to finalization. Retention rates unclear.

The market initially penalized the margin squeeze: the stock fell 1.12% on day 1 post-result (delivery 39.1%, suggesting some forced selling). But by day 3 and day 5, a modest recovery (+1.86%, +1.07%) reflects investor repricing of the growth momentum and catalyst calendar. At ₹14,130, the stock is trading 10.4% below its all-time high but 47.2% above its 52-week low, and remains above its 20-, 50-, and 200-day simple moving averages (₹14,067, ₹13,140, ₹12,269 respectively). This positioning suggests the market has digested the near-term margin pain but is hedging on catalyst execution. FII ownership has ticked down marginally (17.87% vs 18.29% prior quarter), while DII and promoter ownership are stable—consistent with patience from long-term investors despite near-term headwinds. No significant insider selling activity visible in recent bulk/block deals, a mildly positive signal.

What to watch next quarter (and beyond)
  • 1 · Q2 mobile volume delivery vs. order book guidance

    Management guided 9–9.2M units for Q2. Delivery at the high end would support the full-year 32M unit guidance and market share narrative. Miss would signal either market weakness or competitive pressure.

  • 2 · Operating margin stabilization

    If 3.0% OPM holds or stabilizes in Q2–Q3, it's consistent with management guidance (no recovery FY27). If it compresses further, the margin trough goes deeper, raising execution risk on FY28 recovery.

  • 3 · Display factory trial success (Q3 FY27)

    This is the first hard milestone on the FY28 margin recovery roadmap. Any trial delays or customer win delays would push mass production past Q4 and recovery past FY28, materially deferring profitability uplift.

  • 4 · Vivo JV production ramp (Q3 FY27)

    PN3 approved, but manufacturing integration, supply chain, and yield/quality remain unproven. Early production numbers and customer feedback will signal credibility of the Vivo opportunity.

  • 5 · PLI 2 finalized guidelines and anchor customer confirmations

    Currently 'weeks ahead' per management. The export incentive structure (currently 2.5–5%) and localization rules will determine Dixon's actual incremental margin and volume upside from PLI 2. Anchor customer commitments are key.

Dixon Technologies delivered a quarter that looks better on growth than on profitability. Revenue of ₹15,547 crores and market share gains are real, but operating margins at 3.0% reveal a company in transition—caught between the expiry of Mobile PLI1 incentives and the scaling-up of new component production (display, camera) that will only deliver margin accretion in FY28+. The Aditya Infotech fair-value gain of ₹499 crores masks what would otherwise be a profit miss, turning reported PAT into a misleading headline.

This is not a step-change quarter, but a steady execution of a credible multi-year strategy. The bull case rests on four unproven catalysts (Vivo, display, camera, Inventec) all hitting simultaneously in the next 12 months. The bear case is that any one of them slips, and the 3% margin trough persists longer than guided. The verdict sits in the middle: management has transparency and a roadmap, but profitability remains under pressure and execution risk is material.

The single number to track from here is operating margin stabilization. If 3.0% holds through Q2–Q3, the FY28 recovery story gains credibility. If it compresses toward 2.5%, the margin recovery thesis is at risk, and the stock reprices lower despite the growth momentum. Watch Q2 results for the first signal.

Informational and educational content only. Not investment advice.

Dixon Technologies (India) Ltd (DIXON) Q1 FY27 Results, Transcript & Analysis — StockWatch